Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

D-Wave Quantum Inc. Director's Dealing 2025

Dec 23, 2025

30690_dirs_2025-12-23_c5339a31-138d-4886-a4ac-06c19dab375a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: D-Wave Quantum Inc. (QBTS)
CIK: 0001907982
Period of Report: 2025-12-22

Reporting Person: BARATZ ALAN E (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-22 Common Stock, par value $0.0001 per share ("Common Stock") M 793712 $0.91 Acquired 3426875 Direct
2025-12-22 Common Stock, par value $0.0001 per share ("Common Stock") S 793712 $30.1282 Disposed 2633163 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-22 Stock Option (right to buy) $0.91 M 793712 Disposed 2030-05-05 Common Stock, par value $0.0001 per share ("Common Stock") (793712) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.846 2034-01-10 Common Stock, par value $0.0001 per share ("Common Stock") (213232) 213232 Direct

Footnotes

F1: The option exercise and sale of Common Stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025.

F2: Includes 735,087 shares of unvested restricted stock units.

F3: The sales price reported is the weighted average sale price for the number of shares of Common Stock sold. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.

F4: This option has fully vested and, prior to the reported option exercise transaction, was exercisable as to 1,268,107 shares of Common Stock.

F5: This option has fully vested and is exercisable as of the date hereof as to 213,232 shares of Common Stock.